HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment

Abstract Approximately a half of breast tumors classified as HER2-negative exhibit HER2-low-positive expression. We recently described a high instability of HER2-low-positive expression from primary breast cancer (BC) to relapse. Previous studies reporting discordance in HER2 status between baseline...

詳細記述

保存先:
書誌詳細
主要な著者: Federica Miglietta, Gaia Griguolo, Michele Bottosso, Tommaso Giarratano, Marcello Lo Mele, Matteo Fassan, Matilde Cacciatore, Elisa Genovesi, Debora De Bartolo, Grazia Vernaci, Ottavia Amato, Francesca Porra, PierFranco Conte, Valentina Guarneri, Maria Vittoria Dieci
フォーマット: Artigo
言語:Inglês
出版事項: Nature Portfolio 2022-05-01
シリーズ:npj Breast Cancer
オンライン･アクセス:https://doi.org/10.1038/s41523-022-00434-w
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料